Literature DB >> 25256773

The study of the protein complement in myocardial infarction.

Tomasz Ilczuk1, Aleksander Wasiutynski2, Ewa Wilczek2, Barbara Gornicka2.   

Abstract

BACKGROUND: Activation of the complement system during myocardial ischemia and reperfusion results in its injury by multiple processes. The aim of this study was to evaluate contribution of innate, humoral mechanisms of nonspecific immune response in the myocardium subjected to infarction. Complement components and inhibitors were analyzed.
MATERIALS AND METHODS: Myocardial specimens from the archives of Chair and Department of Pathology, Medical University of Warsaw from 2010 to 2013, were used in the study. The examined proteins were evaluated using immunohistochemistry and immunofluorescence techniques. Tissues from 36 men and 14 women, mean age 65.02 ± 14.65, were used in the study. The control group comprised healthy myocardial tissue collected from 10 subjects.
RESULTS: Statistical analysis of IHC reaction for proteins and inhibitors of the complement system and membrane attack complex demonstrated markedly higher immunoreactivity level in the myocardium with ischemic necrosis versus healthy myocardial tissue. A correlation analysis demonstrated statistically significant positive correlation between the examined proteins and inhibitors of the complement system and protectin and membrane attack complex. A significant correlation was not found between immunoreactivity of the examined proteins and clinical and morphological parameters of the analyzed cases.
CONCLUSIONS: Studies have shown that of the complement proteins presence on the surface of the myocardium subjected to ischemic destruction exacerbate.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Complement inhibitors; Complement system; Myocardial infarction

Mesh:

Substances:

Year:  2014        PMID: 25256773     DOI: 10.1016/j.imlet.2014.09.015

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  3 in total

1.  RP105 alleviates myocardial ischemia reperfusion injury via inhibiting TLR4/TRIF signaling pathways.

Authors:  Jun Yang; Chaojun Yang; Jian Yang; Jiawang Ding; Xinxin Li; Qinqin Yu; Xin Guo; Zhixing Fan; Huibo Wang
Journal:  Int J Mol Med       Date:  2018-03-06       Impact factor: 4.101

2.  Complement component 7 is associated with total- and cardiac death in chest-pain patients with suspected acute coronary syndrome.

Authors:  Reidun Aarsetøy; Thor Ueland; Pål Aukrust; Annika E Michelsen; Ricardo Leon de la Fuente; Heidi Grundt; Harry Staines; Ottar Nygaard; Dennis W T Nilsen
Journal:  BMC Cardiovasc Disord       Date:  2021-10-14       Impact factor: 2.298

3.  Evaluation of expression levels and mechanism of complement activation.

Authors:  Xing Wang; An-Heng Liu; Zhong-Wei Jia; Kui Pu; Kang-Yin Chen; Hua Guo
Journal:  Exp Ther Med       Date:  2017-07-26       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.